Abnormal IGF signaling has been confirmed to be related to various malignant tumors, such as those related to breast cancer [174], pancreatic cancer [175], and bladder cancer [176], and is usually associated with poor prognosis [177, 178]. Here, IGF1 is linked to cancer.